Znn3bq.jpeg
²é¿´: 932  |  »Ø¸´: 1

ÀîÊÀÈå

гæ (СÓÐÃûÆø)

[½»Á÷] °¢Ë¹Àû¿µÕÐÆ¸In vitro ADME scientist

¾ßÌ幤×÷µØµã:
ÉϺ£ÕŽ­¸ß¿Æ
н½ð:
10k-15k
ѧÀúºÍÑо¿·½Ïò:
Master
ÕÐÆ¸¸Úλ:
Scientist in DMPK
¹«Ë¾Ãû³Æ:
°¢Ë¹Àû¿µ
ÁªÏµ·½Ê½:
rewsili@163.com

°¢Ë¹Àû¿µÖйú´´ÐÂÖÐÐÄÕÐÆ¸ In vitro DMPK Scientist

Title:  Scientist/Sr. Associate Scientist, DMPK

We are currently seeking a talented and highly self-motivated individual to join our growing DMPK group. The successful candidate will contribute discovery program team in identification of novel molecules for the treatment of cancer and other diseases.
  
Responsibilities include£º
1.Besides supporting routine in vitro ADME assays, one will be asked to design, conduct and report mechanistic ADME studies and IVIVE.
2.Provide high quality of data and effectively communicate to manager, peers and project teams.
3.Stay current on scientific and technology changes, including but not limited to IVIVE, drug transporters and metabolizing enzymes.
4.Analyze in vitro samples by LC/MS/MS.
5.May be trained as project representative and represent DMPK on oncology and non-oncology project teams.

Requirements:
-Ph.D. or M.S. equivalent in Pharmaceutical Sciences, Biochemistry, Medicinal Chemistry or a related field with >3 years working experience;
- Experience in experiment design and performing via In vitro assay to address DMPK potential issues;
Publication record in CYP enzymes and transporter mediated drug disposition and elimination;
- Is able to do problem solving with ¡°can do¡± attitude;
-Strong communication in English is desirable.

Pls contact me rewsili@163.com

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÀîÊÀÈå

гæ (СÓÐÃûÆø)

ÎÒÃÇÊÇ¿ÉÒÔ½ÓÊÜFreshµÄPhDµÄ£¬µ«ÊDZØÐëÒªÓÐIn vitro ADMEµÄʵÑé¾­Ñ飬²¢ÇÒÓÐÓëCYPøÏà¹ØµÄÂÛÎÄ·¢±í£¡

ְλÏÂÖÜÎåÊÇDeadline£¬Ï£Íû´ó¼ÒÄܹ»×¥½ôʱ¼ä£¡´óÐÍÖÆÒ©¹«Ë¾DMPKµÄְλºÜÉÙ£¬Ï£ÍûÓÐÏà¹ØÅóÓѵÄÇë°ïæת·¢Ò»Ï£¬ÔٴθÐл£¡
2Â¥2012-11-16 09:34:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÀîÊÀÈå µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á +28 @ASDF1234 2026-04-08 30/1500 2026-04-10 19:28 by dick_runner
[¿¼ÑÐ] ±¾9 Ò»Ö¾Ô¸Î÷¹¤´ó085601 324Çóµ÷¼Á +5 wysyjs25 2026-04-10 5/250 2026-04-10 16:57 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ¿ØÖƹ¤³Ì085406Êý¶þÓ¢¶þ385£¬Çóµ÷¼Á +6 Ezra_Zhang 2026-04-09 6/300 2026-04-10 16:23 by ¸ßά´º
[¿¼ÑÐ] 273Çóµ÷¼Á +51 ÂóС¶£µ± 2026-04-06 58/2900 2026-04-10 15:54 by jiajinhpu
[¿¼ÑÐ] һ־Ը˫·Ç085400µç×ÓÐÅÏ¢344 Çóµ÷¼Á£¬¶Ô²ÄÁϺͻ¯Ñ§·½ÏòÒ²¸ÐÐËȤ +8 ÎÞÇéµÄСÑò 2026-04-09 9/450 2026-04-10 09:30 by ËÉ»¨¸×1201
[¿¼ÑÐ] ¹¤¿Æ273µ÷¼Á +5 X1999 2026-04-09 6/300 2026-04-10 07:52 by 1753564080
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +3 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-09 3/150 2026-04-09 21:29 by wutongshun
[¿¼ÑÐ] Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á +10 ÔÙæҲҪ³Ô·¹°¡ 2026-04-08 11/550 2026-04-09 19:51 by gong120082
[¿¼ÑÐ] ²ÄÁÏר˶322 +14 ¹þ¹þ¹þºðºðºð¹þ 2026-04-05 14/700 2026-04-09 13:25 by 5268321
[¿¼ÑÐ] ¼ÆËã»ú11408 287 Çóµ÷¼Á +3 LiLe5 2026-04-07 3/150 2026-04-07 23:15 by shanqishi
[¿¼ÑÐ] ר˶085403£¬291·Ö£¬ÓÐÁ½Æª×¨Àû£¬Ò»¹úÒ»½± +3 ¹þ¼ªßä¹þ¼ªßä 2026-04-07 3/150 2026-04-07 18:21 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +17 СÁõͬѧ߹߹ 2026-04-06 18/900 2026-04-07 11:41 by Ê«Óë×ÔÓÉ
[¿¼ÑÐ] 312Çóµ÷¼Á +4 LR6 2026-04-06 4/200 2026-04-07 08:42 by jp9609
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +14 ºôºô£¿~+123456 2026-04-05 14/700 2026-04-06 22:50 by chenzhimin
[¿¼ÑÐ] 085405Èí¼þ¹¤³Ì301·ÖÇóµ÷¼Á£¬×¨Ë¶¿É¿çרҵ£¬ËÄÁù¼¶Òѹý +3 ¾²¾²ÏëÏë 2026-04-05 3/150 2026-04-06 15:23 by nepu_uu
[¿¼ÑÐ] 377Çóµ÷¼Á +6 by.ovo 2026-04-05 6/300 2026-04-05 22:18 by dongzh2009
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +10 ¹þ¹þ¹þºðºðºð¹þ 2026-04-04 10/500 2026-04-05 21:22 by ѧԱ8dgXkO
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
[¿¼ÑÐ] 085602µ÷¼Á ³õÊÔ×Ü·Ö335 +12 19123253302 2026-04-04 12/600 2026-04-05 08:08 by 544594351
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +6 ·¶¸ùÅà 2026-04-04 6/300 2026-04-04 14:27 by ÍÁľ˶ʿÕÐÉú
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û